drugset / Trial / NCT01360671
IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the efficacy of iv sildenafil in term and near term infants with PPHN (persistent pulmonary hypertension of the newborn), by measuring the need for inhaled nitric oxide (iNO) or extracorporeal membrane oxygenation (ECMO) compared to a historical control group not treated with sildenafil.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 0.03 mg/kg | Intravenous |